Image

“Some of these vaccines were crude by today’s standards. In fact, some might not receive broad FDA approval today, but they were effective and timely,” says the Geisel School of Medicine’s Kendall Hoyt in a Conversation opinion piece about the way World War II sped the process of vaccine innovation.

Kendall Hoyt is an assistant professor of medicine at Geisel. She is a Dartmouth Public Voices fellow.